Raffi Asadorian
2016 - Amyris
In 2016, Raffi Asadorian earned a total compensation of $614.4K as Chief Financial Officer at Amyris, a 51% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $28,519 |
|---|---|
| Option Awards | $76,400 |
| Salary | $450,000 |
| Stock Awards | $59,000 |
| Other | $468 |
| Total | $614,387 |
Asadorian received $450K in salary, accounting for 73% of the total pay in 2016.
Asadorian also received $28.5K in non-equity incentive plan, $76.4K in option awards, $59K in stock awards and $468 in other compensation.
Rankings
In 2016, Raffi Asadorian's compensation ranked 10,446th out of 14,075 executives tracked by ExecPay. In other words, Asadorian earned more than 25.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,446 out of 14,075 | 26th |
Division Manufacturing | 4,035 out of 5,489 | 27th |
Major group Chemicals And Allied Products | 1,424 out of 1,895 | 25th |
Industry group Industrial Organic Chemicals | 50 out of 72 | 31st |
Source: SEC filing on April 27, 2017.
Asadorian's colleagues
We found three more compensation records of executives who worked with Raffi Asadorian at Amyris in 2016.
News
AcelRx Pharmaceuticals CEO Vincent Angotti's 2023 pay slips 7% to $1.2M
April 29, 2024
AcelRx Pharmaceuticals CEO Vincent Angotti's 2022 pay falls 47% to $1.3M
August 28, 2023
AcelRx Pharmaceuticals CEO Vincent Angotti's 2021 pay jumps 39% to $2.4M
June 3, 2022
AcelRx Pharmaceuticals CEO Vincent Angotti's 2019 pay jumps 22% to $2.1M
April 24, 2020
AcelRx Pharmaceuticals CEO Vincent Angotti's 2018 pay falls 26% to $1.7M
May 14, 2019